Teleflex Incorporated (NYSE:TFX) Shares Acquired by Thompson Investment Management Inc.

Thompson Investment Management Inc. lifted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 31.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,340 shares of the medical technology company’s stock after buying an additional 800 shares during the period. Thompson Investment Management Inc.’s holdings in Teleflex were worth $594,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Simplify Asset Management Inc. acquired a new position in shares of Teleflex during the third quarter worth approximately $4,800,000. JPMorgan Chase & Co. lifted its position in Teleflex by 14.3% in the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after purchasing an additional 19,466 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in Teleflex by 19.8% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 484 shares of the medical technology company’s stock worth $102,000 after purchasing an additional 80 shares during the period. LGT Capital Partners LTD. lifted its position in Teleflex by 4.2% in the third quarter. LGT Capital Partners LTD. now owns 231,685 shares of the medical technology company’s stock worth $57,300,000 after purchasing an additional 9,411 shares during the period. Finally, Boston Trust Walden Corp lifted its position in Teleflex by 3.9% in the fourth quarter. Boston Trust Walden Corp now owns 294,614 shares of the medical technology company’s stock worth $52,435,000 after purchasing an additional 11,052 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Price Performance

Shares of NYSE:TFX opened at $171.13 on Friday. The stock has a fifty day moving average of $180.04 and a 200-day moving average of $211.25. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a one year low of $170.30 and a one year high of $256.85. The company has a market capitalization of $7.95 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 1.72 and a beta of 1.16.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Truist Financial cut their target price on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Mizuho cut their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Royal Bank of Canada cut their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Finally, StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $252.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.